purpleDx Pulmonary Disease Smartphone App Set for Release
electronRx announced it will launch purpleDx, a smartphone app for cardiopulmonary assessment, at CES 2025.
Read MorePosted by Chris Wolski | Dec 23, 2024 | Flu & Respiratory Infections |
electronRx announced it will launch purpleDx, a smartphone app for cardiopulmonary assessment, at CES 2025.
Read MorePosted by Andy Lundin | Dec 11, 2024 | Diagnostic Technologies |
Researchers developed an optimized pooled testing framework, enabling faster, cost-effective, and accurate infectious disease screening.
Read MorePosted by Andy Lundin | Dec 4, 2024 | Sequencing Systems |
Delve Bio’s Delve Detect is a metagenomic sequencing test capable of quickly identifying over 68,000 pathogens from CSF.
Read MorePosted by Andy Lundin | Dec 3, 2024 | Lung Cancer, Molecular Diagnostics |
Studies validated Biofidelity’s Aspyre Lung diagnostic tech, showcasing its ability to offer genomic profiling for actionable NSCLC variants.
Read MorePosted by Andy Lundin | Nov 14, 2024 | Molecular Diagnostics |
A research team developed a new method for detecting low-abundance proteins in plasma, enhancing early disease detection.
Read More